GROSSMAN D KEITH — SEC insider filings

SEC reporting owner CIK 1218702. 58 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers the 50 most recent of 58 filings on record, filed 2021-05-05 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Outset Medical, Inc. (OM)Director17—18 legs · 57,557 sh · $1,167,23733
NEVRO CORP (NVRO)Director312 legs · 10,200 sh · $938,978—34
MiniMed Group, Inc. (MMED)Director2——2

Insider filings — GROSSMAN D KEITH

FiledFormIssuerReported transactionsSource
2026-10-134MiniMed Group, Inc. (MMED)Grant/award (A): 11,795 @ $0EDGAR
2026-06-054Outset Medical, Inc. (OM)Grant/award (A): 10,667 @ $0EDGAR
2026-03-114MiniMed Group, Inc. (MMED)Grant/award (A): 13,889 @ $0EDGAR
2025-06-044Outset Medical, Inc. (OM)Grant/award (A): 8,983 @ $0EDGAR
2025-04-034NEVRO CORP (NVRO)Disposition to issuer (D): 228,552EDGAR
2025-03-114NEVRO CORP (NVRO)Tax withholding (F): 1,641 @ $5.78EDGAR
2025-03-114Outset Medical, Inc. (OM)Option exercise (M): 187,500 · Grant/award (A): 750 (derivative) @ $200 · Option exercise (M): 750 (derivative) @ $0EDGAR
2025-03-044NEVRO CORP (NVRO)Grant/award (A): 4,750 @ $0 · Tax withholding (F): 1,071 @ $5.72 · Tax withholding (F): 1,017 @ $5.72EDGAR
2024-12-044NEVRO CORP (NVRO)Tax withholding (F): 928 @ $4.26EDGAR
2024-09-054NEVRO CORP (NVRO)Tax withholding (F): 1,020 @ $5.55EDGAR
2024-06-054NEVRO CORP (NVRO)Tax withholding (F): 1,134 @ $9.33EDGAR
2024-06-034Outset Medical, Inc. (OM)Option exercise (M): 31,186 @ $1.11 · Sale (S): 26,230 @ $3.80 · Option exercise (M): 38,117 @ $1.11 · Sale (S): 11,887 @ $3.74 · Option exercise (M): 31,186 (derivative) @ $0 · Option exercise (M): 38,117 (derivative) @ $0EDGAR
2024-05-294Outset Medical, Inc. (OM)Grant/award (A): 25,000 @ $0EDGAR
2024-05-284NEVRO CORP (NVRO)Grant/award (A): 19,169 @ $0EDGAR
2024-04-154NEVRO CORP (NVRO)Tax withholding (F): 3,986 @ $13.12EDGAR
2024-03-134NEVRO CORP (NVRO)Tax withholding (F): 2,184 @ $14.99EDGAR
2024-03-064NEVRO CORP (NVRO)Grant/award (A): 4,750 @ $0 · Tax withholding (F): 1,597 @ $14.51EDGAR
2024-03-054NEVRO CORP (NVRO)Tax withholding (F): 1,403 @ $14.22EDGAR
2023-12-054NEVRO CORP (NVRO)Tax withholding (F): 2,056 @ $18.82EDGAR
2023-10-264NEVRO CORP (NVRO)Tax withholding (F): 6,012 @ $15.75EDGAR
2023-09-064NEVRO CORP (NVRO)Tax withholding (F): 2,193 @ $20.39EDGAR
2023-07-264NEVRO CORP (NVRO)Tax withholding (F): 6,013 @ $24.16EDGAR
2023-06-064NEVRO CORP (NVRO)Tax withholding (F): 2,193 @ $28.27EDGAR
2023-05-314Outset Medical, Inc. (OM)Grant/award (A): 7,681 @ $0EDGAR
2023-04-264NEVRO CORP (NVRO)Grant/award (A): 22,841 @ $0EDGAR
2023-04-134NEVRO CORP (NVRO)Tax withholding (F): 4,263 @ $35.66EDGAR
2023-03-144NEVRO CORP (NVRO)Tax withholding (F): 2,757 @ $30.19EDGAR
2023-03-074NEVRO CORP (NVRO)Tax withholding (F): 8,798 @ $34.43EDGAR
2022-06-014Outset Medical, Inc. (OM)Grant/award (A): 6,880 @ $0EDGAR
2022-04-124NEVRO CORP (NVRO)Tax withholding (F): 4,263 @ $0EDGAR
2022-03-284NEVRO CORP (NVRO)Grant/award (A): 147,644 @ $0 · Tax withholding (F): 77,734 @ $67.08EDGAR
2022-03-214NEVRO CORP (NVRO)Tax withholding (F): 4,875 @ $70.61EDGAR
2022-03-154NEVRO CORP (NVRO)Tax withholding (F): 2,754 @ $64.09EDGAR
2022-03-084/ANEVRO CORP (NVRO)Grant/award (A): 50,000 @ $0EDGAR
2022-03-084NEVRO CORP (NVRO)Purchase (P): 3,200 @ $63.59EDGAR
2022-03-074NEVRO CORP (NVRO)Grant/award (A): 50,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2021-12-214NEVRO CORP (NVRO)Tax withholding (F): 4,874 @ $85.81EDGAR
2021-12-024Outset Medical, Inc. (OM)Sale (S): 1,296 @ $47.92EDGAR
2021-11-024Outset Medical, Inc. (OM)Sale (S): 2,592 @ $55 · Sale (S): 1,296 @ $54.31EDGAR
2021-10-044Outset Medical, Inc. (OM)Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $55 · Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $55 · Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $55 · +6 moreEDGAR
2021-10-044Outset Medical, Inc. (OM)Option exercise (M): 62 @ $1.11 · Sale (S): 62 @ $49.69 · Sale (S): 1,234 @ $49.69 · Option exercise (M): 62 (derivative) @ $0EDGAR
2021-09-214NEVRO CORP (NVRO)Tax withholding (F): 4,874 @ $126.63EDGAR
2021-09-014Outset Medical, Inc. (OM)Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $49.17 · Option exercise (M): 1,296 (derivative) @ $0EDGAR
2021-08-274Outset Medical, Inc. (OM)Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $45 · Option exercise (M): 1,296 (derivative) @ $0EDGAR
2021-08-174NEVRO CORP (NVRO)Purchase (P): 7,000 @ $105.07EDGAR
2021-07-024Outset Medical, Inc. (OM)Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $49.23 · Option exercise (M): 1,296 (derivative) @ $0EDGAR
2021-06-224NEVRO CORP (NVRO)Tax withholding (F): 4,874 @ $160.45EDGAR
2021-06-044Outset Medical, Inc. (OM)Grant/award (A): 3,288 @ $0EDGAR
2021-06-024Outset Medical, Inc. (OM)Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $47.92 · Option exercise (M): 1,296 (derivative) @ $0EDGAR
2021-05-054Outset Medical, Inc. (OM)Option exercise (M): 2,592 @ $1.11 · Sale (S): 2,274 @ $57.87 · Sale (S): 100 @ $58.50 · Sale (S): 218 @ $59.79 · Option exercise (M): 2,592 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1218702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs